NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT02945800 2026-04-02Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory SarcomaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Completed59 enrolled 11 charts